GRM1 and cancer: In neuronal and non-neuronal cancer, the activation group 1 mGluRs (mGluR1 and 5) seems to be tumor-promoting, thus the strategies that inhibit the expression of group 1 mGluRs can be important for treating different types of cancer in which group 1 mGluRs is involved.